GLP-1 Pipeline Update: November 2024 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Clinical Pharmacist, Drug Information Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Director, Pipeline Lisa Schweizer, PharmD, JD Director, Clinical Program Management Deputy Editor DISCLAIMER The drug pipeline is fluid
Both are types of combined hormonal contraceptives that deliver estrogen and progestin, just like the combined pill, but through the skin or vaginal lining, not the digestive system
doi: 10.1080/00207454.2021.1924707 108 HolstJJ
Tirzepatide: The Leading Choice Mounjaro and Zepbound, brand names for Tirzepatide, have become the preferred options in the realm of weight loss
Primary fiber: Continue your foundation fiber at full dose